Conversion to IPX066, extended-release carbidopa-levodopa, in advanced Parkinson’s disease patients: Dosing patterns
Objective: Describe the dosing patterns in advanced Parkinson's disease (PD) patients who completed conversion to IPX066 from other levodopa formulations. Background: IPX066 is an extended-release…Proprioceptive training as a means to enhance sensorimotor function in Parkinson’s disease
Objective: To identify whether proprioceptive function in Parkinson's disease (PD) can be enhanced by specialized visuomotor training that emphasizes precise movements and determine if such…Feasibility and preliminary efficacy of a telehealth approach to group tango instruction for people with Parkinson’s disease
Objective: To determine the feasibility and preliminary efficacy of group adapted tango class for individuals with Parkinson's disease (PD) taught through telehealth technology. Background: Group…Taking specialist clinics into community nursing homes
Objective: Evaluate the effectiveness of delivering specialist Parkinson's care in community care home settings. Background: Our drive to improve older people's care has led to…LSVT-BIG© case studies: A snapshot of observations
Objective: This case presentation will outline two clients treated with LSVT –BIG and share some observations of the technique. Background: It is estimated that seven…A crossover study of pretarsal and preseptal injections of botulinum toxin type A (BTX-A) in the treatment of hemifacial spasm and blepharospasm
Objective: To compare the efficacy, patient satisfaction, and side effects between pretarsal and preseptal injection sites on BTX-A treatment in abnormal orbicularis oculi contraction in…Applicability study of a multitask cognitive and motor exercise program for individuals with Parkinson´s disease: The COGWEB CNS Move Program
Objective: To test the applicability of a new rehabilitation program for people with Parkinson´s disease combining web-based cognitive training with motor exercises. Background: Parkinson´s disease…Real-world safety of deep brain stimulation in patients with ≤7.5 years between disease onset and device implant
Objective: The intent of this analysis was to characterize real-world safety of deep brain stimulation (DBS) in patients with ≤7.5 years between Parkinson's disease (PD)…Effect of STN-DBS on impulse control disorder and affective behavioral complications of Parkinson’s disease: A 1-year longitudinal study
Objective: In this 1-year prospective study, we evaluated the effect of bilateral deep brain stimulation (DBS) of the subthalamic nucleus (STN) on neuropsychiatric complications of…Clinical outcome of subthalamic deep brain stimulation in Parkinson’s disease – The Helsinki experience
Objective: To evaluate the efficacy and adverse effects of subthalamic deep brain stimulation (STN-DBS) in patients with advanced Parkinson's disease (PD) and the possible correlation…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 207
- Next Page »